Regarding scoline apnoea all are true except
**Question:** Regarding scoline apnoea, all are true except
A. Coline is a brand name for suxamethonium (a muscle relaxant).
B. Suxamethonium causes a rapid and transient blockade of neuromuscular transmission.
C. Suxamethonium is a short-acting muscle relaxant with a duration of action of around 15-30 minutes.
D. Suxamethonium does not affect the respiratory centre or cause apnoea.
**Correct Answer:** D. Coline (short for suxamethonium) does not affect the respiratory centre or cause apnoea.
**Core Concept:**
Scoline apnoea refers to the temporary cessation of breathing due to the blockade of neuromuscular transmission by a neuromuscular blocking agent, particularly succinylcholine (suxamethonium). Succinylcholine is a short-acting, non-depolarizing muscle relaxant that blocks the neuromuscular junction by reversibly binding to the AChR (acetylcholine receptor) and preventing the release of acetylcholine at the neuromuscular junction.
**Why the Correct Answer is Right:**
Succinylcholine, also known as coline, is a powerful, rapid-acting neuromuscular blocking agent that blocks the neuromuscular junction by competitively inhibiting acetylcholine binding to the nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. This results in the temporary cessation of neuromuscular transmission and muscle relaxation.
Suxamethonium has a duration of action of around 15-30 minutes, making it suitable for use in procedures lasting between 15 to 60 minutes. However, it does not affect the respiratory centre or cause apnoea. Although succinylcholine is a potent neuromuscular blocking agent, its effect on the respiratory centre is minimal due to the following reasons:
1. Succinylcholine has a fast onset and offset time, ensuring that it does not interfere with the respiratory centre for an extended period.
2. Succinylcholine does not cross the blood-brain barrier, preventing it from affecting the central nervous system, including the respiratory centre.
3. Succinylcholine does not interfere with the automatic respiratory centre (CNS), which is responsible for spontaneous breathing.
**Why Each Wrong Option is Incorrect:**
A. As explained above, succinylcholine's primary action is on the neuromuscular junction, not the respiratory centre.
B. Succinylcholine's effect is limited to the neuromuscular junction and does not cross the blood-brain barrier, making option B incorrect as well.
C. Succinylcholine's duration of action is relatively short, and it does not affect the respiratory centre for an extended period.
D. Succinylcholine does not interfere with the automatic respiratory centre, which is responsible for automatic breathing (option C).
**Clinical Pearls:**
1. Succinylcholine is used for rapid sequence intubation, particularly in emergency situations and situations where rapid